Glenmark Pharmaceuticals? Finacea generic infringes Bayer patent: court
 

Glenmark Pharmaceuticals? Finacea generic infringes Bayer patent: court
NEW YORK (Reuters) - India's Glenmark Pharmaceuticals' proposed generic version of Bayer AG's Finacea, a gel for treating the common skin condition rosacea, infringes Bayer's patent, a U.S. court ruled on Monday.


http://rc.feedsportal.com/r/23456618.../7/rc/1/rc.img

http://rc.feedsportal.com/r/23456618.../7/rc/2/rc.img

http://rc.feedsportal.com/r/23456618.../7/rc/3/rc.img

http://da.feedsportal.com/r/23456618...55/sc/7/a2.img
http://adchoice.feedsportal.com/r/23...5/sc/7/ach.imghttp://pi.feedsportal.com/r/23456618...5/sc/7/a2t.imghttp://pi2.feedsportal.com/r/2345661.../sc/7/a2t2.imghttp://i1.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...wo:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...wo:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/fTG6rdNEoCk